<unk>  (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol<unk>  (EDBu), an estrogen, hydroxyprogesterone<unk>  (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women. It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection. The medication was developed by 1957. It is no longer available.
Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone caproate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate
Estradiol hexahydrobenzoate/hydroxyprogesterone caproate/testosterone hexahydrobenzoate
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate
Testosterone acetate/testosterone undecanoate/testosterone valerate
Estradiol benzoate/testosterone isobutyrate
Estradiol benzoate/estradiol phenylpropionate/testosterone propionate/testosterone phenylpropionate/testosterone isocaproate